Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JHANELLE E GRAY

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1376599340
CMS profile
17284
Location
TAMPA, FL

General Payments · PY2018–2024

$215,273.64

  • Reported across 158 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$45,033.89

28 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Gilead Sciences, Inc. $7,878.78 1
Acerta Pharma LLC $7,666.26 8
Eli Lilly and Company $4,503.89 3
PFIZER INC. $4,420.00 2
Janssen Biotech, Inc. $4,150.04 3
Coherus Biosciences Inc. $3,898.32 2
Amgen Inc. $3,430.00 2
Takeda Pharmaceuticals U.S.A., Inc. $2,625.00 1
Merck Sharp & Dohme Corporation $2,345.00 1
AstraZeneca UK Limited $2,045.00 2
Genentech USA, Inc. $1,984.00 2
Daiichi Sankyo Inc. $87.60 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $18,110.65 18
PY2019 $14,557.03 32
PY2020 $39,733.78 14
PY2021 $12,089.94 13
PY2022 $15,128.88 12
PY2023 $70,619.47 41
PY2024 $45,033.89 28

Payment records · PY2024 (28)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $1,372.00 07/30/2024 Consulting Fee Undisputed 01/23/2026 1117566900 CMS
Amgen Inc. $2,058.00 07/30/2024 Consulting Fee Undisputed 01/23/2026 1117566902 CMS
AstraZeneca Pharmaceuticals LP $20.33 02/23/2024 Food and Beverage Undisputed 01/23/2026 1110536352 CMS
AstraZeneca Pharmaceuticals LP $75.00 05/31/2024 Food and Beverage Undisputed 01/23/2026 1110535474 CMS
AstraZeneca Pharmaceuticals LP $25.00 05/31/2024 Food and Beverage Undisputed 01/23/2026 1110536826 CMS
AstraZeneca Pharmaceuticals LP $135.00 06/03/2024 Food and Beverage Undisputed 01/23/2026 1110545699 CMS
AstraZeneca Pharmaceuticals LP $2,400.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 1110538697 CMS
AstraZeneca Pharmaceuticals LP $23.43 11/19/2024 Food and Beverage Undisputed 01/23/2026 1110537619 CMS
AstraZeneca Pharmaceuticals LP $1,662.50 12/09/2024 Consulting Fee Undisputed 01/23/2026 1110545045 CMS
AstraZeneca Pharmaceuticals LP $3,325.00 12/19/2024 Consulting Fee Undisputed 01/23/2026 1110538819 CMS
AstraZeneca UK Limited $1,995.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 1110541415 CMS
AstraZeneca UK Limited $50.00 09/07/2024 Food and Beverage Undisputed 01/23/2026 1110545271 CMS
Coherus Biosciences Inc. $3,750.00 06/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1147274570 CMS
Coherus Biosciences Inc. $148.32 06/01/2024 Food and Beverage Undisputed 01/23/2026 1147274574 CMS
Daiichi Sankyo Inc. $87.60 02/23/2024 Food and Beverage Undisputed 01/23/2026 1089427971 CMS
Eli Lilly and Company $103.89 02/23/2024 Food and Beverage Undisputed 01/23/2026 1135022522 CMS
Eli Lilly and Company $2,800.00 02/27/2024 Consulting Fee Undisputed 01/23/2026 1135022524 CMS
Eli Lilly and Company $1,600.00 02/27/2024 Consulting Fee Undisputed 01/23/2026 1135066831 CMS
Genentech USA, Inc. $1,875.00 06/28/2024 Consulting Fee Undisputed 01/23/2026 1133032653 CMS
Genentech USA, Inc. $109.00 06/28/2024 Food and Beverage Undisputed 01/23/2026 1133032657 CMS
Gilead Sciences, Inc. $7,878.78 05/29/2024 Consulting Fee Undisputed 01/23/2026 1133598915 CMS
Janssen Biotech, Inc. $2,100.00 05/17/2024 Consulting Fee Undisputed 01/23/2026 1078494217 CMS
Janssen Biotech, Inc. $125.04 05/30/2024 Food and Beverage Undisputed 01/23/2026 1078493503 CMS
Janssen Biotech, Inc. $1,925.00 06/28/2024 Consulting Fee Undisputed 01/23/2026 1078492412 CMS
Merck Sharp & Dohme LLC $2,345.00 10/21/2024 Consulting Fee Undisputed 01/23/2026 1141658648 CMS
PFIZER INC. $3,700.00 01/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131311055 CMS
PFIZER INC. $720.00 06/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131918275 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,625.00 11/26/2024 Consulting Fee Undisputed 01/23/2026 1144958296 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.